ADT vs GILD · P/E 13, rev $2.59B vs P/E 18, rev $7.80B
ADT Inc (ADT) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
ADT Inc (ADT) is a security & protection services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ADT revenue for 2026-06-30 was $2.59B. Net income was $322.2M. ADT currently screens at market cap $7.09B and trailing P/E 13.0.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ADT currently screens at market cap $7.09B and trailing P/E 13.0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ADT and GILD stock pages for the full models.
Not investment advice.